Ren He Xu
Keine laufenden Positionen mehr
Profil
Ren He Xu was the founder of ImStem Biotechnology, Inc. which was founded in 2012, where he held the title of Director & Chief Scientific Officer.
He also worked as an Independent Director at NanHua Bio-medicine Co., Ltd.
Dr. Xu earned a doctorate degree from Bar-Ilan University in 1994 and another doctorate degree from the University of Tokyo in 1999.
He also earned a graduate degree from Central South University in 1987 and an undergraduate degree from the University of South China in 1983.
Ehemalige bekannte Positionen von Ren He Xu
| Unternehmen | Position | Ende |
|---|---|---|
| LANDFAR BIO-MEDICINE CO., LTD | Director/Board Member | - |
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Founder | - |
Ausbildung von Ren He Xu
| Bar-Ilan University | Doctorate Degree |
| University of Tokyo | Doctorate Degree |
| Central South University | Graduate Degree |
| University of South China | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LANDFAR BIO-MEDICINE CO., LTD | Retail Trade |
| Private Unternehmen | 1 |
|---|---|
ImStem Biotechnology, Inc.
ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Health Technology |
